Concepedia
Statistics
Publications
8
Citations
372
H-Index
Active since
2014
Affiliations
Sanofi (United States)(Current)
Ege University
University of Michigan
Christian Medical College, Vellore
Eulji University
Shauna Andersson is an author at Sanofi (United States) specializing in pharmacology, medicine, and hematology.
Publications per year
2014–2024
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial
Guy Young, Alok Srivastava, Kaan Kavaklı et al. · The Lancet · 2023 · 121 citations
Medicine, Pharmacology, Pharmacotherapy +4
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial
Alok Srivastava, Savita Rangarajan, Kaan Kavaklı et al. · The Lancet Haematology · 2023 · 88 citations
Medicine, Hematology, Pharmacology +5
Dosage of X‐linked Toll‐like receptor 8 determines gender differences in the development of systemic lupus erythematosus
Ben Umiker, Shauna Andersson, Luis E. Fernández et al. · European Journal of Immunology · 2014 · 57 citations · Full text
Life Sciences, Genetics, Immunology +17
Fitusiran prophylaxis in people with hemophilia A or B who switched from prior BPA/CFC prophylaxis: the ATLAS-PPX trial
Gili Kenet, Beatrice Nolan, Bülent Zülfikar et al. · Blood · 2024 · 41 citations · Full text
Medicine, Hematology, Pharmacology +15
Long-term safety and efficacy of fitusiran prophylaxis, and perioperative management, in people with hemophilia A or B
Steven W. Pipe, Toshko Lissitchkov, Pencho Georgiev et al. · Blood Advances · 2024 · 21 citations · Full text
Medicine, Hematology, Pharmacology +17
1–5 of 8